Skip to content
  • Media
  • Investors
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Boards
  • Contact

Category: Clinicians

New Experience with Transarterial Micro-Perfusion (TAMP) Presented at GEST 2019, May 11, 2019

Illustration of RenovoCath Two Balloon Catheter System

http://renovorx.com/wp-content/uploads/2019/05/GEST2019.pdf

Trans-pulmonary artery selective chemotherapy delivery to lung using a double balloon-occlusion catheter: feasibility study in swine Presented at SIR 2019 Annual Meeting, March 23-28, 2019

https://www.jvir.org/article/S1051-0443%2818%2932263-2/fulltext

Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System Journal of Vascular & Interventional Radiology, September 2018

https://tinyurl.com/bdetdpsx

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma Journal of Pancreatic Cancer, August 2017

Injection directly into tumor ball

https://www.liebertpub.com/doi/abs/10.1089/pancan.2017.0011

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors Presented at AHPBA Annual Meeting, April 2, 2017

http://renovorx.com/wp-content/uploads/2017/05/AHPBA_Oral-Presentation_Rosemurgy_2017-04-02-2.pdf

Pancreatic Cancer: Chemoembolization Using A Double Balloon Catheter Presented at AIM Symposium, November 14, 2016

Illustration of RenovoRx Two Balloons Delivery System

http://renovorx.com/wp-content/uploads/2016/07/AIM_2016_Pancreatic-TACE_Cynamon.pdf

Pancreas Club Abstract: Is Intra-Arterial with Targeted Delivery of Gemcitabine Safe in Treatment of Patients with Loco-Regional Pancreatic Tumors? May 20-21, 2016

http://renovorx.com/wp-content/uploads/2016/07/Rosemurgy-A_Pancreas-Club-Abstract.pdf

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors Poster presented to 50th Annual Pancreas Club Meeting, May 20-21, 2016

http://renovorx.com/wp-content/uploads/2016/07/Pancreas-Club-Poster_PPT_FINAL.pdf

IHPBA 2016 Abstract: Intra-arterial and Tumor-Targeted Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer, April 20-23, 2016

http://renovorx.com/wp-content/uploads/2016/07/IHPBA-2016-abstract.pdf

← Previous

RenovoCath is FDA-cleared for targeted delivery of chemotherapy to selected sites in the peripheral vascular system. The company is studying the use of RenovoCath-delivered gemcitabine for treatment of LAPC in an ongoing clinical trial conducted under an IND.

Facebook-f X-twitter Linkedin-in Youtube

Menu

  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • 2570 W. El Camino Real, Suite 640
    Mountain View, CA 94040
  • (650) 284-4433
  • info@renovorx.com
© 2026 RenovoRx®. All rights reserved.

Privacy Statement | Terms of Use